Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Argus Health
Accenture
US Department of Justice
Johnson and Johnson
AstraZeneca
Medtronic
Baxter
Covington
Fuji

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202513

« Back to Dashboard

NDA 202513 describes GELNIQUE 3%, which is a drug marketed by Allergan Sales Llc and is included in one NDA. There are four patents protecting this drug. Additional details are available on the GELNIQUE 3% profile page.

The generic ingredient in GELNIQUE 3% is oxybutynin. There are sixteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the oxybutynin profile page.
Summary for 202513
Tradename:GELNIQUE 3%
Applicant:Allergan Sales Llc
Ingredient:oxybutynin
Patents:4
Therapeutic Class:Genitourinary Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:GEL, METERED;TRANSDERMALStrength3%
Approval Date:Dec 7, 2011TE:RLD:Yes
Patent:➤ Sign UpPatent Expiration:Apr 26, 2020Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF PATIENTS WITH AN OVERACTIVE BLADDER WITH SYMPTOMS OF URINARY FREQUENCY, URGENCY, OR URGE INCONTINENCE
Patent:➤ Sign UpPatent Expiration:Apr 26, 2020Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF PATIENTS WITH AN OVERACTIVE BLADDER WITH SYMPTOMS OF URINARY FREQUENCY, URGENCY, OR URGE INCONTINENCE
Patent:➤ Sign UpPatent Expiration:Jun 25, 2022Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Baxter
AstraZeneca
Healthtrust
Colorcon
Cerilliant
McKinsey
Farmers Insurance
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot